nygazet.com logo
Postmenopause: FDA approves first libido
health

Postmenopause: FDA approves first libido

•
1 min read
•
Medical News Today

The FDA approved Addyi (flibanserin), a libido-enhancing drug, in postmenopausal women under the age of 65. Experts explain what to expect, the side effects, and other alternatives.

On December 15, 2025, the U.S. FDA approved Addyi (flibanserin) for the treatment of hypoactive sexual desire disorder (HSDD) in postmenopausal women under the age of 65. Addyi was previously approved in 2015 for the treatment of HSDD in premenopausa... [6246 chars]

Read Original Article

Source: Medical News Today

Visit Source

Share this article

TwitterFacebook
Back to health news